VEGF −460T → C polymorphism and its association with VEGF expression and outcome to FOLFOX-4 treatment in patients with colorectal carcinoma

Very low prevalence of XPD K751Q polymorphism and its association with XPD expression and outcomes of FOLFOX-4 treatment in Asian patients with colorectal carcinoma

(2009) Jiun-I. Lai et al.   CANCER SCIENCE

Influence ofGSTP1I105V polymorphism on cumulative neuropathy and outcome of FOLFOX-4 treatment in Asian patients with colorectal carcinoma

(2009) Yen-Chung Chen et al.   CANCER SCIENCE

Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer

(2008) G. Lurje et al.   ANNALS OF ONCOLOGY

UGT1A1*28 polymorphism predicts irinotecan-induced severe toxicities without affecting treatment outcome and survival in patients with metastatic colorectal carcinoma

(2008) Chun-Yu Liu et al.   CANCER

ERCC1codon 118 C→T polymorphism associated withERCC1expression and outcome of FOLFOX-4 treatment in Asian patients with metastatic colorectal carcinoma

(2008) Peter Mu-Hsin Chang et al.   CANCER SCIENCE

Vascular Endothelial Growth Factor Polymorphisms −1154 G/A and −460 C/T Are Not Associated with VEGF mRNA Expression and Susceptibility to Sporadic Colon Cancer

(2008) Tamara Cacev et al.   DNA AND CELL BIOLOGY